TickerFacts.

Sonoma Pharmaceuticals, Inc. (SNOA): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-03-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$12.11M
Year ended 2026-03-31
$13.39M
Trailing 12 months to 2026-06-30
+11.3%
3-year compound annual growth
+0.1%
5-year compound annual growth
+6.1%
10-year compound annual growth
2011-03-31: $3.61M2012-03-31: $4.03M2013-03-31: $4.71M2014-03-31: $5.27M2015-03-31: $6.57M2016-03-31: $6.72M2017-03-31: $7.16M2018-03-31: $9.35M2019-03-31: $10.09M2020-03-31: $9.81M2021-03-31: $12.07M2022-03-31: $8.63M2023-03-31: $8.79M2024-03-31: $7.99M2025-03-31: $8.82M2026-03-31: $12.11M$12.11M
2011-03-31 Cost of Revenue (USD) 2026-03-31
Period endedCost of RevenueChange YoYSource filing
2026-03-31$12.11M+37.3%2026-06-16, From 2025-04-01
2025-03-31$8.82M+10.4%2026-06-16, From 2024-04-01
2024-03-31$7.99M-9.2%2025-06-17, From 2023-04-01
2023-03-31$8.79M+1.9%2024-06-17, From 2022-04-01
2022-03-31$8.63M-28.5%2023-06-21, From 2021-04-01
2021-03-31$12.07M+23.1%2022-07-13, From 2020-04-01
2020-03-31$9.81M-2.8%2021-07-14, From 2019-04-01
2019-03-31$10.09M+7.9%2019-07-01, From 2018-04-01
2018-03-31$9.35M+30.6%2019-07-01, From 2017-04-01
2017-03-31$7.16M+6.5%2018-06-26, From 2016-04-01
2016-03-31$6.72Mn/c2017-06-28, From 2015-04-01
2015-03-31$6.57M+24.6%2016-06-21, From 2014-04-01
2014-03-31$5.27M+11.9%2015-06-16, From 2013-04-01
2013-03-31$4.71M+16.8%2014-06-30, From 2012-04-01
2012-03-31$4.03M+11.5%2013-06-25, From 2011-04-01
2011-03-31$3.61Mn/a2012-06-21, From 2010-04-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$12.11M+37.3%
Spectral AI, Inc. (MDAI)2025-12-31$10.72M-34.2%
Nephros Inc (NEPH)2025-12-31$7.16M+31.7%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$6.90M+14.8%
DarioHealth Corp. (DRIO)2025-12-31$9.69M-29.6%
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$3.65M-16.7%
Profound Medical Corp. (PROF)2025-12-31$4.71M+29.2%
Biotricity Inc. (BTCY)2026-03-31$3.05M-5.5%
Allurion Technologies, Inc. (ALUR)2025-12-31$5.66M-46.6%

Compare SNOA, MDAI, NEPH, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗